Late mortality of long-term survivors of childhood cancer

Maryna Krawczuk-Rybak

doi:10.5114/wo.2011.24321

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2011
vol. 15

Send email

Copy url:

abstract:

Review paper

Late mortality of long-term survivors of childhood cancer

Maryna Krawczuk-Rybak

Wspolczesna Onkol 2011; 15 (4): 240-245

DOI: https://doi.org/10.5114/wo.2011.24321

Online publish date: 2011/09/09

View full text Get citation

PlumX metrics:

In the last four decades there has been enormous progress in the treatment for childhood cancer; the present 5-year survival rate is estimated to be 80%. The increased population of cancer survivors gives us the possibility to assess life quality as well as the late effects of anticancer treatment. In multicentre studies, it has been shown that 60% of survivors have at least one late effect, and one third experience severe or life-threatening sequelae. Survivors of childhood cancers are at risk of recurrence of primary malignancy, development of second cancer and chronic disease of the respiratory and cardiovascular system, which increase the mortality rate. Other late complications, such as diseases affecting kidneys, digestive system or bones, and hormonal and metabolic disturbances lead to deterioration of life quality. This report presents treatment-related factors that increase mortality of cancer survivors by contributing to the development of second cancers, cardiotoxicity or pulmonary complications.

keywords:

Late mortality of long-term survivors of childhood cancer

Maryna Krawczuk-Rybak

children, cancer survivors, late effects, second cancers, cardiotoxicity, lung toxicity, late mortality